1023 related articles for article (PubMed ID: 6460854)
21. 99mTc-hydroxymethane diphosphonate: a new bone imaging agent with a low tin content.
Domstad PA; Coupal JJ; Kim EE; Blake JS; DeLand FH
Radiology; 1980 Jul; 136(1):209-11. PubMed ID: 6446106
[TBL] [Abstract][Full Text] [Related]
22. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
23. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
Coleman RE; Meier CA; Rubens RD; Fogelman I
Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
[TBL] [Abstract][Full Text] [Related]
24. External and biopsy determination of preoperative Tc-99m MDP femoral-head labeling in fracture of the femoral neck: concise communication.
Strömqvist B; Brismar J; Hansson LI; Thorngren KG
J Nucl Med; 1984 Aug; 25(8):854-8. PubMed ID: 6235328
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the kinetics of methylene-diphosphonate (MDP) and dicarboxypropan-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy.
Schroth HJ; Hausinger F; Garth H; Oberhausen E
Eur J Nucl Med; 1984; 9(12):529-32. PubMed ID: 6526051
[TBL] [Abstract][Full Text] [Related]
26. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
Bergqvist L; Brismar J; Cederquist E; Darte L; Naversten Y; Palmer J
Acta Radiol Diagn (Stockh); 1984; 25(3):217-23. PubMed ID: 6236672
[TBL] [Abstract][Full Text] [Related]
27. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
28. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters.
Pauwels EK; Feitsma RI
Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535
[TBL] [Abstract][Full Text] [Related]
29. The visualization of femoral vessels in delayed bone scans--a sign of arteriosclerosis? A comparison of 99mTc-MDP and 99mTc-DPD.
Lantto T; Järvi K; Toivio I; Vähätalo S; Vorne M
Eur J Nucl Med; 1989; 15(5):265-8. PubMed ID: 2759127
[TBL] [Abstract][Full Text] [Related]
30. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
Schuemichen C; Krause T; Umbach G; Wolff T
Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
[TBL] [Abstract][Full Text] [Related]
31. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
32. [Four cases of diffuse bone metastasis with increased uptake in 99mTc-MDP bone scintigraphy].
Dannoura R; Morita S; Kikuchi S; Ohta M; Ohtake H
Kaku Igaku; 1984 Nov; 21(11):1521-5. PubMed ID: 6241644
[No Abstract] [Full Text] [Related]
33. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
[TBL] [Abstract][Full Text] [Related]
34. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
[TBL] [Abstract][Full Text] [Related]
35. Effects of dissolved oxygen on Tc-99m methylene diphosphonate: concise communication.
Coupal JJ; Kim EE; DeLand FH
J Nucl Med; 1981 Feb; 22(2):153-6. PubMed ID: 6450824
[TBL] [Abstract][Full Text] [Related]
36. The impact of different bone tracers and acquisition times on image quality of equine bone scintigraphy.
Mageed M; Dyab S; Swagemakers JH; Gerlach K
Vet Radiol Ultrasound; 2022 Sep; 63(5):593-600. PubMed ID: 35666549
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effect of 99mTc-DPD and 99mTc-MDP on experimentally-induced osteoarthritis in the stifle joint of the dog.
Lee JY; Lee WG; Kim JH; Kang SS; Bae CS; Koong SS; Choi SH
In Vivo; 2005; 19(4):781-5. PubMed ID: 15999549
[TBL] [Abstract][Full Text] [Related]
38. A computer assisted comparison of 99Tcm-methylene-diphosphonate and 99Tcm-pyrophosphate bone imaging.
Büll U; Pfeifer JP; Niendorf HP; Tongendorff J
Br J Radiol; 1977 Sep; 50(597):629-36. PubMed ID: 198055
[TBL] [Abstract][Full Text] [Related]
39. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
40. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
